Home›Stock Screener›Amrutanjan Health Care

Amrutanjan Health Care Share Price Today | Stock Price & Amrutanjan Health Care Share Screener

AMRUTANJAN Pharmaceuticals
Live Share Price NSE
₹518.10
▲ 4.90 (0.95%)
2026-10-05 00:00:00
Live Share Price BSE
₹517.00
▲ 3.20 (0.62%)
2026-10-05 00:00:00

As of October 5, 2026, the live Amrutanjan Health Care share price (NSE: AMRUTANJAN) is ₹518.10 on NSE and ₹517.00 on BSE, up 0.95% from the previous close, with shares trading between ₹511.00 and ₹524.00 in today's trading session, and a 52-week range of ₹488.25–₹741.50. Check AMRUTANJAN 52-week chart for the annual price range and momentum. Use the Amrutanjan Health Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Amrutanjan Health Care opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Amrutanjan Health Care Market Cap ₹1,486.01 Cr.
AMRUTANJAN P/E Ratio (TTM) -
Amrutanjan Health Care P/B Ratio 3.95
EPS (TTM) ₹14.08
Dividend Yield 0.97%
Debt to Equity 0.02
AMRUTANJAN 52 Week High ₹741.50
Amrutanjan Health Care 52 Week Low ₹488.25
Operating Margin -
Profit Margin -
AMRUTANJAN Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹140.00
Total Equity ₹109.00

Amrutanjan Health Care Share Price Chart

Track the current stock price of Amrutanjan Health Care with an interactive chart. Analyse AMRUTANJAN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Amrutanjan Health Care stock quote in one place.

The quote of ₹518.10 sits between the 52-week low of ₹488.25 and the 52-week high of ₹741.50, and the latest session moved 0.95% from the previous close.

Amrutanjan Health Care Company Profile - Fundamental Screener

Screen Amrutanjan Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMRUTANJAN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE098F01031.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE098F01031

Amrutanjan Health Care Balance Sheet Screener

Screen AMRUTANJAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2016, total assets were ₹140, up from ₹124 in 2015.

Latest statistics put total assets at ₹140 and shareholder funds at ₹109, with a leverage ratio of 0.02.

Item 2016 2015

Assets

Total Assets 140 124
Current Assets 101 83
Fixed Assets 29 24

Liabilities

Total Liabilities 0 0
Current Liabilities 4 3
Non-Current Liabilities 0 0

Shareholders' Equity

Total Equity 109 95
Share Capital 3 3
Reserves & Surplus 106 92

Amrutanjan Health Care Income Statement Screener - Profit & Revenue Analysis

Screen Amrutanjan Health Care income statement and profit fundamentals. Analyze AMRUTANJAN quarterly results. Amrutanjan Health Care reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2016-March, shows revenue of ₹192 and net profit of ₹21.

Item None-None 2016-March 2015-March

Revenue and Expenses

Revenue 0 192 171
Expenses 0 156 143

Operating Costs and Margins

EBITDA 0 37 28
Operating Profit % 0.00% 16.00% 14.00%
Depreciation 0 3 3
Interest 0 0 1

Profit and Earnings

Profit Before Tax 0 32 24
Tax 0 12 9
Net Profit 0 21 15
EPS 0.00 14.08 10.31

Amrutanjan Health Care Cash Flow Screener - Liquidity Fundamentals

Screen AMRUTANJAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2016-March, operating activities generated ₹21, and net cash flow was an inflow of ₹12.

Over the same period, investing activities provided ₹4 and financing activities used ₹13.

Item 2016-March 2015-March

Cash from Operations and Investing

Operating Activities 21 18
Investing Activities 4 -5

Financing and Net Cash

Financing Activities -13 -12
Net Cash Flow 12 2

Amrutanjan Health Care Shareholding Pattern Screener

See Amrutanjan Health Care shareholding pattern with promoter, FII, and DII holdings. Check Amrutanjan Health Care promoter holding and ownership changes for AMRUTANJAN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 46.52%, foreign institutions 2.17%, domestic institutions 12.66% and the public 32.20%, spread across 45,805 shareholders.

The shareholder count was 45,805 in 2026-Mar, compared with 45,135 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 46.52% 46.52% 46.52% 46.52% 46.52% 46.52% 50.59% 50.59%

Institutional Investors

FII Holding 2.17% 2.44% 2.30% 2.41% 2.38% 2.27% 1.38% 1.55%
DII Holding 12.66% 12.28% 11.41% 12.70% 12.90% 13.00% 7.29% 7.32%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 32.20% 32.06% 33.56% 32.28% 32.18% 32.09% 34.17% 33.87%
Other Holding 6.45% 6.70% 6.22% 6.09% 6.02% 6.13% 6.57% 6.67%
Shareholder Count 45,805 45,135 51,674 49,431 47,954 46,675 62,664 57,169

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Amrutanjan Health Care. Amrutanjan Health Care dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹4.90 per unit for 2026-March, a yield of 0.97%, compared with ₹4.60 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹4.90, ₹4.60 and ₹4.60 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹4.90 0.97%
2025-March ₹4.60 0.93%
2024-March ₹4.60 0.71%
2023-March ₹4.60 0.74%
2022-March ₹4.60 0.80%
2021-March ₹4.20 0.53%
2020-March ₹2.10 0.37%
2019-March ₹2.15 0.65%
2018-March ₹3.05 0.99%
2017-March ₹3.85 1.42%

Amrutanjan Health Care Stock Index Membership - Nifty & Sensex

See which indices include Amrutanjan Health Care stock. Check AMRUTANJAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Amrutanjan Health Care is not part of any tracked indices.
Only major market indices are tracked in our system.

Amrutanjan Health Care Market Events Screener - Corporate Actions

Get Amrutanjan Health Care corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Amrutanjan Health Care stock events that may affect AMRUTANJAN share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 23, 2026, with a record date of September 23, 2026.

It is followed by Dividend dated September 11, 2026 and Quarterly Result Announcement dated August 11, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-23 2026-09-23 Annual General Meeting NA -5.63%
2026-09-11 2026-09-11 Dividend ₹ 2.90 /share -11.61%
2026-08-11 2026-08-11 Quarterly Result Announcement NA 2.46%
2026-05-08 2026-05-08 Quarterly Result Announcement NA -3.93%
2026-02-06 2026-02-07 Dividend ₹ 1.00 /share 10.34%
2026-02-03 2026-02-03 Quarterly Result Announcement NA -2.77%
2025-11-18 2025-11-18 Dividend ₹ 1.00 /share 0.36%
2025-11-10 2025-11-10 Quarterly Result Announcement NA -1.32%
2025-09-23 2025-09-23 Annual General Meeting NA 15.67%
2025-09-16 2025-09-16 Dividend ₹ 2.60 /share 6.32%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -4.43%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 5.45%
2025-02-18 2025-02-18 Dividend ₹ 1.00 /share -4.60%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -5.10%
2024-11-22 2024-11-22 Dividend ₹ 1.00 /share 0.77%

Amrutanjan Health Care Competitors Screener - Peer Stocks Comparison

Screen AMRUTANJAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 436,871 36.83 61,674 12.69% 11,565 47.42
Divis Laboratories 248,041 86.00 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 184,554 86.72 13,886 20.34% 2,138 48.14
Zydus Life Science 115,820 25.96 27,658 17.64% 5,026 61.81
Cipla 110,006 33.29 29,045 2.24% 3,870 44.03
Laurus Labs 106,609 98.39 6,868 22.01% 890 58.00
Dr Reddys Laboratories 102,265 32.77 35,059 3.90% 4,158 69.59
Mankind Pharma 101,436 50.84 14,636 14.85% 1,938 64.24
Aurobindo Pharma 96,111 26.41 34,145 5.56% 3,503 54.69
Lupin 92,921 16.97 29,039 26.75% 5,356 34.02

Amrutanjan Health Care Company Announcements - News & Reports Screener

Screen AMRUTANJAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 1, 2026.

The next most recent announcements are dated September 30, 2026 and September 29, 2026.

Date Update Actions
2026-10-01 Closure of Trading Window -
2026-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-28 Business Responsibility and Sustainability Reporting (BRSR) -
2026-08-28 Reg. 34 (1) Annual Report. -
2026-08-12 Investor Presentation For The Quarter Ended 30Th June 2026 -
2026-08-11 Record Date For The Final Dividend And AGM -
2026-08-11 Board Meeting Outcome for Financial Results And Outcome Of The Board Meeting -
2026-08-06 Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 -
2026-08-05 Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June 2026 -
2026-08-05 Commissioning Of New Manufacturing Facility -
2026-08-05 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-08-05 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-01 Intimation Of Under Regulation 30 Read With Clause 20 Of Para A Of Part A Of Schedule Ill Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-07-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-24 Closure of Trading Window -
2026-06-19 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-06-19 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-05-28 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-27 Reconstitution Of Committees Of Board Of Directors. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹518.10, within a 52-week range of ₹488.25 to ₹741.50. The P/B ratio is 3.95. Market capitalisation stands at ₹1,486.01 Cr and the dividend yield is 0.97%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 2 balance sheet periods, 3 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.